Editorial: CD4+ T Cells in Cancer Immunotherapies

Front Immunol. 2021 Sep 6:12:737615. doi: 10.3389/fimmu.2021.737615. eCollection 2021.
No abstract available

Keywords: CD4; T lymphocyte; cancer; immune checkpoint inhibitor (ICI); immunotherapy.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Animals
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Immunotherapy, Adoptive* / adverse effects
  • Lymphocytes, Tumor-Infiltrating / drug effects*
  • Lymphocytes, Tumor-Infiltrating / immunology
  • Lymphocytes, Tumor-Infiltrating / metabolism
  • Neoplasms / immunology
  • Neoplasms / metabolism
  • Neoplasms / therapy*
  • Phenotype
  • Prognosis
  • T-Lymphocytes, Helper-Inducer / drug effects*
  • T-Lymphocytes, Helper-Inducer / immunology
  • T-Lymphocytes, Helper-Inducer / metabolism
  • T-Lymphocytes, Helper-Inducer / transplantation*
  • Tumor Microenvironment

Substances

  • Immune Checkpoint Inhibitors